NCT02324686View on ClinicalTrials.gov

Vitamin K Supplementation in Patients on Hemodialysis

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 18, 2017

Study Completion Date

December 18, 2017

Conditions
End Stage Renal Failure on DialysisAtrial Fibrillation
Interventions
DRUG

vitamin K1

Vitamin K1 400 mcg orally three times a week on dialysis days for four months

Trial Locations (1)

M5G 2C4

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02324686 - Vitamin K Supplementation in Patients on Hemodialysis | Biotech Hunter | Biotech Hunter